Pseudallescheriasis in the 21st century (Q36278064)

13 August 2017

1 reference

title

Pseudallescheriasis in the 21st century (English)

1 reference

13 August 2017

Thomas A O'Bryan

1

1 reference

13 August 2017

publication date

1 October 2005

1 reference

Expert Review of Anti-infective Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

765-773

1 reference

Infections due to emerging and uncommon medically important fungal pathogens

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Clinical significance of Pseudallescheria boydii: a review of 10 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Allescheria boydii infections in the immunosuppressed host

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolificans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Isolation of potentially pathogenic fungi from polluted water and sewage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Invasive mold infections in allogeneic bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Fungal keratitis caused by Scedosporium apiospermum: report of two cases and review of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Septic arthritis due to Scedosporium apiospermum: case report and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Disseminated Pseudallescheria boydii infection in a nonimmunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Scedosporium apiospermum (Pseudallescheria boydii) endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Lung abscess due to Pseudallescheria boydii in the course of acute leukaemia. Report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Treatment of Scedosporium apiospermum brain abscesses with posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Successful treatment of chronic meningitis caused by Scedosporium apiospermum with oral voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Pseudoallescheria boydii pneumonia and empyema: a rare complication of heart transplantation cured with voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Voriconazole in the treatment of invasive mold infections in transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

The changing face of invasive fungal infections in hematopoietic cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Management of fever in neutropenic patients with different risks of complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Design of efficacy trials of cytokines in combination with antifungal drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Potted plants in hospitals as reservoirs of pathogenic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

Case Report. Atypical cutaneous pseudallescheriosis refractory to antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14787210.3.5.765

21 January 2018

Identifiers

DOI

10.1586/14787210.3.5.765

1 reference

13 August 2017

1 reference